In the wake of the COVID-19 pandemic, research teams around the globe are racing to develop vaccines and therapeutic options for the disease. Accurate animal models are essential for verifying the pathogenesis and immune mechanisms of the illness to accelerate development of vaccines and other drug-based interventions into the clinical trial stage. The global situation has resulted in a significant demand for ACE2 mouse models for research and development (R&D) purposes.
Cyagen now provides validation data reports of our humanized ACE2 mouse models for SARS-CoV-2 drug screening and vaccine development.
|Project Type||Background Strain||Genotype||List Price/Mouse||Promotion Price/Mouse|
|ACE2 Humanized Model||C57BL/6J||Heterozygous||$800||$500|
1. Minimum order quantity: ≥ 10 mice, any combination of model types.
2. Eligibility: Academic customers in US & EU. Contact us for eligibility in other regions or for commercial use.
3. Promotion Period: Request a quote before March 26, 2021.
<< Please complete the form to access Validation Data reports for our ACE2 Mouse Models & receive a project quote from our client solutions team: